Unit 5
Unit 5
Biomaterials
There are 2 common definitions of biomaterials:
A material derived from, or produced by, biological organisms
These are also called biologically derived materials.
A material used for a biological purpose such as a biomedical
application like treating an injury or growing biological cells.
Biomaterials
Moldability: The ease with which materials can be shaped into the desired form.
Sterilizability: The ability to be effectively sterilized without compromising material
properties.
Immunogenicity:
Polymers:
Polymers are large molecules composed of
repeating subunits.
Natural polymer : collagen or hyaluronic acid
Synthetic polymer :polyethylene, polylactic
poly(glycolic acid), poly(lactide-co-
acid (PLA), polyglycolic acid (PGA), and their glycolic acid), poly(lactic acid),
copolymers (PLGA). polycaprolactone poly(4-
hydroxybutyrate) and polydioxanone
They are used in a variety of applications
such as in soft tissue implants, drug delivery
systems, and sutures.
.
Types of Biomaterials
Composites:
These are engineered materials made from
two or more constituent materials with
significantly different physical or chemical Amalgam
properties.
Composite
They aim to combine the best properties of
the included materials.
Composite fillings are tooth
Composite fillings are tooth coloured and coloured and are made from
powdered glass quartz, silica or
are made from powdered glass quartz, silica other ceramic particles added to a
or other ceramic particles added to a resin resin base.
base.
Doctors, researchers, and bioengineers use biomaterials for the following broad
range of applications:
Bone Grafting
Bone grafting is a surgical procedure that
uses transplanted bone to repair and
rebuild diseased or damaged bones.
Bone is removed from the other body part
and used to grafting in damaged bone
•Structural and Functional Complexity: Bone is a highly complex tissue, both structurally and functionally.
Replicating its hierarchical organization, mechanical properties, and biological functions is extremely
challenging.
•Vascularization: Creating engineered bone with adequate blood vessel networks (vascularization) to supply
nutrients and remove waste is a major hurdle. Poor vascularization can lead to cell death and graft failure
•Pore Size and Porosity: Designing scaffolds with optimal pore size and porosity for cell growth and nutrient
flow, while maintaining mechanical integrity, is challenging.
•Cell Survival: Ensuring the survival and functional integration of transplanted cells within the host tissue,
especially in large bone defects, is a critical challenge. Delivery Systems: Developing delivery systems that can
provide sustained, localized release of growth factors at therapeutic levels without causing adverse reactions is
complex.
•Dosage and Timing: Determining the appropriate dosage and timing for growth factor release to mimic natural
bone healing processes requires more research.
•Affordability: Making bone tissue engineering solutions affordable and accessible to a wide range of patients
remains a significant challenge.